Forbes -
19 Sep 2012 22:18
Two new studies published in the Journal of the American College of Cardiology offer hope but not, yet, compelling evidence to support less burdensome requirements for dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation.
Share this Article
Comment on this Article
Please to comment